Hisky Academic







 中文 EN

Hisky Academic

iLivTouch® Clinical research

MAFLD Assessment of liver health Viral hepatitis Liver Cancer and Cirrhosis Evaluate the efficacy of medication Others

Comparison of FibroTouch and FibroScan for the assessment of fibrosis in chronic hepatitis B patients

To perform a comparative assessment of the performance of FibroTouch and FibroScan in patients with hepatitis B.

Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B

To investigate the correlation of liver stiffness measured by FibroTouch (FT) and FibroScan (FS) with Ishak fibrosis score in patients with chronic hepatitis B.

Comparison of FibroTouch and FibroScan for the assessment of fibrosis in chronic hepatitis B patients

To explore the diagnostic values of FibroTouch and FibroScan for liver fibrosis in CHB patients.

Influencing factors for FibroTouch measurements in chronic hepatitis B patients based on liver pathology

To investigate the changes in positive staining of CD34, CK7, and CK19 and amount of fibrous collagen deposition in patients with CHB and the pathological basis affecting FibroTouch measurements.

Clinical study of FibroTouch and six serological models for assessing the degree of liver fibrosis in patients with chronic hepatitis B

To evaluate the using value of FibroTouch and six serological models in detecting the degree of liver fibrosis in CHB patients.
Attempt to provide reference for accurate diagnosis.

Multicenter prospective study to validate a new transient elastography device for staging liver fibrosis in patients with chronic hepatitis B (IF=3.5)

To validate the operational and diagnostic performances of a new device for transient elastography (TE), FibroTouch, for liver fibrosis in patients with chronic hepatitis B (CHB).

Efficiency of transient elastography in diagnosis of liver fibrosis in patients with HIV/HCV co infection

To investigate the efficiency of transient elastography (TE) in the diagnosis of liver fibrosis in patients with human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infection.

Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients (IF=0.6)

To evaluate the diagnostic performance of the fat attenuation parameter (FAP) measured by FibroTouch.
A new algorithm to assess hepatic steatosis in CHB patients, in comparison to liver biopsy.